A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.
Study Type
OBSERVATIONAL
Enrollment
2,800
Marcin Straburzyński
Dźwierzuty, Warmian-Masurian Voivodeship, Poland
Department of Neurology, Wrocław Medical University
Wroclaw, Poland
Headache phenotype
Classification of reported headache according to International Classification of Headache Disorders
Time frame: in the preceding year
Migraine burden
Consequences of the disease measured by the Migraine Disability Assessment Test
Time frame: in the preceding year
Monthly headache days
Number of days per month
Time frame: in the preceding month
Monthly headache days
Number of days per year
Time frame: in the preceding year
Time from last headache professional consultation
Number of months
Time frame: in the preceding 10 years
Migraine diagnosed by headache professional
yes/no
Time frame: in the preceding 10 years
Age at diagnosis
years
Time frame: from the onset of headache (time frame up to 99 years)
Comoribidities
Disease according to International Classsification of Disease 10
Time frame: in the preceding year
Type of previous headache professional consultation
Name of headache profession/speciality
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: in the preceding 10 years
Number of consultations in the last year
Number 0-100
Time frame: in the last 12 months
Number of consultations in the last year because of headaches
Number 0-100
Time frame: in the last 12 months
Number of days spent in hospital in the last year because of headaches
Number 0-100
Time frame: in the last 12 months
Acute treatment used
Name of abortive medication
Time frame: in the preceding 10 years
Preventive treatment used
Name of abortive medication
Time frame: in the preceding 10 years
Acute treatment frequency
Number of days per month
Time frame: in the last 3 months
Preventive treatment frequency
Number of months form the last dose
Time frame: in the last 12 months
Preventive treatment effectiveness
Likert scale
Time frame: in the last 12 months
Employment
Type of employment
Time frame: in the last 12 months
Time spent at work
Number of hours per week
Time frame: in the last 12 months
Work absence due to headache
Number of days per month
Time frame: in the last month
Presenteeism
Number of days per month
Time frame: in the last month
PHQ-9 Patient Health Questionnaire
Number
Time frame: in the last 2 weeks
Sinus headache
Number of days
Time frame: in the last 3 months
Sinonasal symptoms accompanying headache
Type of symptoms
Time frame: in the last 12 months
Sinonasal symptoms not associated with headache
Type of symptom
Time frame: in the last 12 months
COVID-19 association with headache
Likert scale
Time frame: in the last 2 years
COVID-19 vaccine association with headache
Likert scale
Time frame: in the last year